Title:
Electrochemical separation of Ytterbium from Lutetium for the production of Lu-177 medical radioisotope
Tech ID:
2022-002
Status:
Active
Category:
Radiochemical Processing and Medical Isotope Production
Executive Statement:
A simple and fast electrochemical method to separate Lutetium-177 from Ytterbium target materials for medical applications.
Description:
This technology provides an efficient electrochemical process to selectively separate Ytterbium from Lutetium, enabling the rapid and cost-effective production of Lu-177, a valuable radioisotope used in targeted cancer therapies. The method improves purity and yield while reducing processing time compared to conventional techniques.
Key Advantages:
- Rapid and selective separation process
- Reduces production costs by recovering expensive Lu-177 efficiently
- Improves purity and quality of the final medical radioisotope
- Simple and scalable method adaptable to existing production lines
Problems Solved:
- High cost and complexity in separating Lu-177 from Ytterbium targets
- Long processing times limiting isotope availability
- Contamination and low purity in traditional separation methods
Marketing Opportunity:
- Production of Lu-177 for radiopharmaceuticals in cancer treatment
- Nuclear medicine and diagnostic imaging industries
- Radioisotope supply for hospital and research facilities
Inventors:
- Artem Gelis
- Allison Cicero
UNIVERSITY OF NEVADA, LAS VEGAS
Available Technologies
